Using both brain function (PET) and anatomical structure (MR) imaging studies, Italian researchers--within the context of an Italian-British collaboration--discovered that degenerative and dysfunctional events occur in individuals many years before the onset of Huntington's disease--particularly in the brain's white matter--an area not previously considered primarily involved with the disease. In fact, the brain's white matter "progressively reduced" as individuals approached the first disease symptoms, according to a study published in February's Journal of Nuclear Medicine.

"Our observations--made by analyzing the results of the largest group of subjects studied to date--may suggest new methodologies and drug trials for therapy," said Ferdinando Squitieri, M.D., Ph.D., who works in the Neurogenetics Unit and Centre for Rare Diseases of IRCCS Neuromed in Pozzilli, Isernia, Italy. "It is possible to approach the disease at the presymptomatic stage by monitoring the brain tissue volumes and the basal ganglia and cortex dysfunction. If so, we may be able to prevent Huntington's disease before onset symptoms by using proper drugs," added the co-author of "Brain White-Matter Volume Loss and Glucose Hypometabolism Precede the Clinical Symptoms of Huntington's Disease."

Huntington's Disease is a devastating, hereditary, degenerative brain disorder, which slowly diminishes an individual's ability to walk, think, talk and reason. About one out of every 10,000 Americans has the disease, which has one of the highest rates of patient suicide, said Squitieri. The disease profoundly affects the lives of entire families, as an affected person becomes totally dependent on others for his or her care. Each child of a parent affected by the disease has a 50/50 chance of inheriting the gene that causes the disease.

The Huntington's gene has been determined; however, it's unclear how the gene leads to damage of nerve cells in the brain, including the basal ga
'"/>

Contact: Maryann Verrillo
mverrillo@snm.org
703-708-9000
Society of Nuclear Medicine
15-Feb-2006

Page: 1 2 3
Related biology news :

1. Combination Lyme disease vaccine proteins patented
2. Combination of technologies works best against E. coli
3. Orexigen reports positive phase II results for Excalia Combination-Therapy to treat obesity
4. Combination therapy shows promising results in patients with advanced lung cancer
5. Combination therapy for mouse model of human inherited blindness
6. Combination therapy leads to partial recovery from spinal cord injury in rats
7. Combination of Lipitor and Celecoxib
8. Combination therapy boosts effectiveness of telomere-directed cancer cell death
9. Combination hormone therapy doubles breast density and quadruples risk of abnormal mammograms
10. New imaging method clarifies nutrient cycle
11. Methodist, University of Houston, Cornell combine biomedical imaging expertise